fda compounding semaglutide news october 2025 Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, End U.S. FDA | The FDA

For example, somatostatin, a hormone principally produced in the nervous and digestive systems, reduces GLP-1 production

185,204 Importantly, the inclusion of some progestins in postmenopausal hormone therapy has been linked to increased breast cancer risk and may reverse the cardioprotective benefits of estrogen therapy

Alternatively, bone broth, mineral water, and adding a pinch of salt to meals can help maintain electrolyte balance naturally

These often occur within a week of starting semaglutide, though noticeable changes in weight or blood sugar take longer

Otherwise, theyd just pop some Tums and call it a night

Naunyn-Schmiedebergs Arch Pharmacol 396:669682